FDA seeks math of similarity

Share this article:

The FDA is looking for mathletes, of a sort. Regulatory Focus reports that the FDA is looking to create a mathematical model that will help regulators assess the sameness of generics and maybe even biosimilars.

RF says the Center for Drug Evaluation and Research will oversee the three-year project which will cost around $1 million.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.